A business in context

GLSI research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001493152-26-037147

  2. 4 · Ownership change

    Report date 2026-07-28 · 0001493152-26-035310

  3. 4 · Ownership change

    Report date 2026-07-27 · 0001493152-26-035085

  4. 4 · Ownership change

    Report date 2026-07-23 · 0001493152-26-034675

  5. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001493152-26-027150

  6. 10-K · Annual report

    Report date 2025-12-31 · 0001493152-26-026651

  7. 4 · Ownership change

    Report date 2026-01-13 · 0001493152-26-002319

  8. 4 · Ownership change

    Report date 2026-01-12 · 0001493152-26-002112

  9. 4 · Ownership change

    Report date 2025-12-31 · 0001493152-26-000229

  10. 4 · Ownership change

    Report date 2025-12-30 · 0001493152-26-000006

  11. 4 · Ownership change

    Report date 2025-12-18 · 0001493152-25-028424

  12. 8-K · Current report

    Report date 2025-12-18 · 0001493152-25-028361 · Items 5.07

  13. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001493152-25-023539

  14. DEF 14A · Proxy statement

    Report date 2025-11-03 · 0001493152-25-020623

  15. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001641172-25-024066

  16. 8-K · Current report

    Report date 2025-07-19 · 0001641172-25-020843 · Items 4.01,9.01

  17. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001641172-25-011731

  18. 10-K · Annual report

    Report date 2024-12-31 · 0001641172-25-004819

  19. 8-K · Current report

    Report date 2024-12-19 · 0001493152-24-050777 · Items 5.07

  20. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001493152-24-045938

  21. DEF 14A · Proxy statement

    Report date 2024-11-01 · 0001493152-24-043327

  22. 10-Q · Quarterly report

    Report date 2024-06-30 · 0001493152-24-032278

  23. 8-K · Current report

    Report date 2024-06-13 · 0001493152-24-024035 · Items 1.01,3.02,9.01

  24. 10-Q · Quarterly report

    Report date 2024-03-31 · 0001493152-24-020710

  25. 10-K · Annual report

    Report date 2023-12-31 · 0001493152-24-014625

  26. 8-K · Current report

    Report date 2024-02-14 · 0001493152-24-007223 · Items 4.01,9.01

  27. 8-K · Current report

    Report date 2024-02-14 · 0001493152-24-006664 · Items 8.01,9.01

  28. 8-K · Current report

    Report date 2023-12-15 · 0001493152-23-045048 · Items 5.07

  29. DEF 14A · Proxy statement

    Report date 2023-10-24 · 0001493152-23-038176

  30. 10-Q · Quarterly report

    Report date 2023-09-30 · 0001493152-23-037702

  31. 10-Q · Quarterly report

    Report date 2023-06-30 · 0001493152-23-029605

  32. 10-Q · Quarterly report

    Report date 2023-03-31 · 0001493152-23-018539

  33. 8-K · Current report

    Report date 2023-04-13 · 0001493152-23-012053 · Items 8.01

  34. 10-K · Annual report

    Report date 2022-12-31 · 0001493152-23-010284

  35. 8-K · Current report

    Report date 2023-03-13 · 0001493152-23-007316 · Items 8.01

  36. 8-K · Current report

    Report date 2022-12-09 · 0001493152-22-035047 · Items 5.07

  37. 10-Q · Quarterly report

    Report date 2022-09-30 · 0001493152-22-032057

  38. DEF 14A · Proxy statement

    Report date 2022-10-19 · 0001493152-22-028917

  39. 10-Q · Quarterly report

    Report date 2022-06-30 · 0001493152-22-022956

  40. 8-K · Current report

    Report date 2022-07-12 · 0001493152-22-019051 · Items 1.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 5 transaction rows5PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

5 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-07-29
2026-07-30
Patel SnehalP · Purchase
Acquired
Common Stock700.013.1
2026-07-28
2026-07-30
Patel SnehalP · Purchase
Acquired
Common Stock1500.013.59
2026-07-27
2026-07-29
Patel SnehalP · Purchase
Acquired
Common Stock1500.013.62
2026-07-24
2026-07-27
Patel SnehalP · Purchase
Acquired
Common Stock1100.012.88
2026-07-23
2026-07-27
Patel SnehalP · Purchase
Acquired
Common Stock2500.013.14

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001799788Greenwich LifeSciences, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    No USD annual revenue periods with complete CPI coverage are available. Non-USD statements are not converted with U.S. CPI.

    Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

    Explore the CPI history ↗